Your browser doesn't support javascript.
loading
Difference in immunosuppressant dose requirement when transitioning to isavuconazole from other azoles in thoracic transplant recipients.
Kozuch, Jade M; Burt, Carrie; Afshar, Kamyar; Aslam, Saima; Yung, Gordon; Mariski, Mark; Golts, Eugene; Feist, Ashley.
Affiliation
  • Kozuch JM; Department of Pharmacy, University of California San Diego, La Jolla, California, USA.
  • Burt C; Department of Pharmacy, Scripps Memorial Hospital, La Jolla, California, USA.
  • Afshar K; Division of Pulmonary and Critical Care, University of California San Diego, La Jolla, California, USA.
  • Aslam S; Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, California, USA.
  • Yung G; Division of Pulmonary and Critical Care, University of California San Diego, La Jolla, California, USA.
  • Mariski M; Department of Pharmacy, University of California San Diego, La Jolla, California, USA.
  • Golts E; Division of Cardiothoracic Surgery, University of California San Diego, La Jolla, California, USA.
  • Feist A; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, USA.
Transpl Infect Dis ; 26(1): e14209, 2024 Feb.
Article in En | MEDLINE | ID: mdl-38059638
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Azoles / Immunosuppressive Agents / Nitriles Limits: Humans Language: En Journal: Transpl Infect Dis Journal subject: TRANSPLANTE Year: 2024 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Azoles / Immunosuppressive Agents / Nitriles Limits: Humans Language: En Journal: Transpl Infect Dis Journal subject: TRANSPLANTE Year: 2024 Type: Article Affiliation country: United States